About Precia Group

Precia’s leadership team is passionate about ensuring that women who participate in clinical trials are valued partners throughout the process. They have decades of experience in women’s health in the US and globally. They have led initiatives to accelerate research efforts to improve reproductive health and address adverse pregnancy outcomes.

The Precia team has significant expertise in standardizing data collection, creation of care plans, maternal and neonate biobanking, global harmonization of maternal cohorts and establishing research efforts in nontraditional clinical settings.

Through the Precia Network, the team is creating new research opportunities for women in the geographic areas where they receive care. They have developed easy-to-use tools to simplify participation (online eligibility screening, etc.). Further, they have been intentional about ensuring that network site Principal Investigators are women.

Donna Russell, MHA
CEO

Donna Russell

Donna Russell is co-founder and CEO of Precia Group, a Contract Research Organization founded in 2020 to expand the number of women in studies, especially in early phases. The company is currently focused on women’s reproductive health, pregnancy and menopause but will expand its service areas to include all aspects of women’s health throughout the lifespan.

Prior to Precia Group, Ms. Russell worked in maternal health research, in the US as a Director of Research at Seattle Children’s Research Institute and globally, consulting with the Bill & Melinda Gates Foundation and other major funders and NGOs. She has extensive experience establishing biobanks to support pregnancy cohorts and research networks in the community-setting; and harmonizing collections across multiple networks to enable large-scale multi-omics studies.

Ms. Russell also serves on the board of Valley Medical Center, a community hospital affiliated with the University of Washington and has a deep understanding of how to successfully integrate research into the clinical setting to ensure high-quality, diverse, equitable studies.

Amber Sexton, MPA
COO

Amber Sexton

Amber Sexton oversees clinical research operations, including regulatory, training, and study management protocols. She has 15 years of experience in research, biobanking, data management, and governance and has a strong background in establishing lean processes to build scalable infrastructure.

Prior to joining Precia Group, Amber managed the data governance strategy and program at the Washington State Health Care Authority. She spent 10 years at Seattle Children’s Hospital, where she managed a global biobank supporting translational research to improve maternal and newborn health. Amber developed an innovative regulatory and consent structure ensuring federal compliance with human subjects research regulations, while allowing for broad access to specimens and data by researchers. She and her team developed standards for specimen and data collection which were utilized for harmonizing Gates Foundation-funded global maternal cohorts. Amber started her research career as a research associate for the largest pediatric diabetes study in the US, SEARCH for Diabetes in Youth.

Amber received her Bachelor of Science from Seattle Pacific University in Psychology.  She holds a postgraduate degree in Public Administration with a concentration in Public Policy.